MDMA Shows New Promise for Trauma, but the Drug Alone Is Not a Cure
The illegal substance—paired with intensive therapy and hard work—dramatically improves PTSD symptoms
The illegal substance—paired with intensive therapy and hard work—dramatically improves PTSD symptoms
For the first time, a randomized controlled trial shows the psychedelic offers potent, if short-term, relief in comparison with an SSRI
After Pfizer and Moderna, a slew of other candidates could fill gaps in efficacy, production or distribution
Oregon became the first state to legalize therapeutic use of the drug as new research affirms its benefits for treating depression
Synthetic peptides that mimic human antibodies for COVID-19 could be cheaper and easier to produce
Psilocybin shows higher remission rate than SSRI drugs in a U.K. study
A large U.S. survey found that users of LSD and similar drugs were no more likely to have mental-health conditions than other respondents
Each boy raises the risk of death by 7 percent. They may be energetically more demanding to breast-feed
Unique proteins in these amphibians cast doubt on the existence of any latent potential for limb regeneration
The cells of these cancer-immune rats reach a point at which they die en masse in a bout of cell suicide. The process could provide some clue to how to activate the same process in human cells...
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account